First-line intra-arterial chemotherapy (IAC) with epirubicin and mitoxantrone in locally advanced breast cancer.
Fiorentini G, Tsetis D, Bernardeschi P, Varveris C, Rossi S, Kalogeraki A, Athanasakis E, Dentico P, Kanellos P, Biancalani M, Almarashdah S, Zacharioudakis G, Saridaki Z, Chalkiadakis G, Xynos E, Zoras O.
Fiorentini G, et al.
Anticancer Res. 2003 Sep-Oct;23(5b):4339-45.
Anticancer Res. 2003.
PMID: 14666649
Clinical Trial.